Related Experiment Video

Updated: Jul 18, 2026

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

Idiopathic pulmonary fibrosis

R M du Bois1

  • 1Royal Brompton National Heart and Lung Hospital, London, United Kingdom.

Annual Review of Medicine
|January 1, 1993
PubMed

Insights

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with limited treatment options. Emerging diagnostic and therapeutic strategies offer new hope for managing IPF.

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Medical Imaging
  • Molecular and Cellular Biology

Background:

  • Idiopathic pulmonary fibrosis (IPF) presents a significant mortality rate, with 50% of patients dying within five years.
  • Current treatments for IPF are largely ineffective, and disease incidence is rising globally.
  • There is a critical unmet need for novel diagnostic and therapeutic approaches to IPF.

Purpose of the Study:

  • To explore innovative diagnostic techniques for idiopathic pulmonary fibrosis.
  • To review emerging therapeutic strategies for idiopathic pulmonary fibrosis management.
  • To highlight the potential of integrating advanced imaging and molecular biology in IPF care.

Main Methods:

  • Review of recent advancements in medical imaging relevant to IPF diagnosis.
  • Analysis of current research in molecular and cellular biology for IPF therapeutic targets.
  • Synthesis of evidence on novel diagnostic and management approaches for IPF.

Main Results:

  • Advanced imaging techniques show promise for earlier and more accurate IPF detection.
  • Molecular and cellular biology research is identifying new pathways for IPF intervention.
  • Combination strategies integrating imaging and molecular approaches may offer improved IPF outcomes.

Conclusions:

  • New imaging and molecular biology advances are paving the way for improved IPF diagnosis.
  • Novel therapeutic strategies are emerging to modulate the IPF disease process.
  • Integrated approaches hold potential for transforming the management of idiopathic pulmonary fibrosis.

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...